Abstract
Deoxyribonucleases (DNases) are key enzymes for digesting DNA. Abnormalities in the function of these enzymes may contribute to the development of anti-DNA antibodies in systemic lupus erythematosus (SLE). In this study, we used bovine DNase 1-coated ELISA plates to screen anti-DNase antibodies in SLE patients. About 62% of the sera of SLE patients (63/101) were positive for anti-DNase antibodies compared to only 8% of normal controls (8/98). A positive correlation was also found between the concentrations of anti-DNase and anti-DNA antibodies in sera of SLE patients. Affinity-purified anti-DNase immunoglobulin G (IgG) from pooled sera of SLE patients bound to bovine DNase as well as DNA. A synthetic peptide, corresponding to the catalytic site of DNase, was able to completely inhibit the binding of anti-DNase IgG to DNase. In addition to bovine DNase, the anti-DNase IgG also bound to and inhibited the enzymatic activities of DNase present in streptococcal supernatants and human urine. Immunization of lupus-prone NZB/NZW mice with bovine DNase enhanced the production of anti-DNase and DNA antibodies, and accelerated the occurrence of proteinuria. Taken together, these results suggest that DNase-inhibitory antibodies which recognize a conserved epitope near the catalytic site of DNase may act in the pathogenesis of SLE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Balada E, Ordi-Ros J, Hernanz S, Villarreal J, Cortes F, Vilardell-Tarres M, Labrador M. DNASE I mutation and systemic lupus erythematosus in a Spanish population: Comment on the article by Tew et al. Arthritis Rheum 46:1974–1976;2002.
Chitrabamrung S, Rubin RL, Tan EM. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1:55–60;1981.
Ito K, Minamiura N, Yamamoto T. Human urine DNase I: Immunological identity with human pancreatic DNase I, and enzymic and proteochemical properties of the enzyme. J Biochem (Tokyo) 95:1399–1406;1984.
Kishi K, Yasuda T, Ikehara Y, Sawazaki K, Sato W, Iida R. Human serum deoxyribonu-clease I (DNase I) polymorphism: Pattern similarities among isozymes from serum, urine, kidney, liver, and pancreas. Am J Hum Genet 47:121–126;1990.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685;1970.
Liao TH. Deoxyribonuclease I and its clinical applications. J Formos Med Assoc 96:481–487;1997.
Liu YF, Liao TH. Mechanism for inhibition of deoxyribonuclease activity by antisera. J Protein Chem 16:75–82;1997.
Macanovic M, Lachmann PJ. Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay. Clin Exp Immunol 108:220–226;1997.
Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. Features of systemic lupus erythematosus in DNase1-deficient mice. Nat Genet 25:177–181;2000.
Oefner C, Suck D. Crystallographic refinement and structure of DNase I at 2 A resolution. J Mol Biol 192:605–632;1986.
Pan CQ, Ulmer JS, Herzka A, Lazarus RA. Mutational analysis of human DNase I at the DNA binding interface: Implications for DNA recognition, catalysis, and metal ion dependence. Protein Sci 7:628–636;1998.
Puccetti A, Madaio MP, Bellese G, Migliorini P. Anti-DNA antibodies bind to DNase I. J Exp Med 181:1797–1804;1995.
Rosenthal AL, Lacks SA. Nuclease detection in SDS-polyacrylamide gel electrophoresis. Anal Biochem 80:76–90;1977.
Shuster AM, Gololobov GV, Kvashuk OA, Bogomolova AE, Smirnov IV, Gabibov AG. DNA hydrolyzing autoantibodies. Science 256:665–667;1992.
Simmonds MJ, Heward JM, Kelly MA, Allahabadia A, Foxall H, Gordon C, Franklyn JA, Gough SC. A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves' disease: Comment on the article by Rood et al. Arthritis Rheum 46:3109–3110;2002.
Suck D, Lahm A, Oefner C. Structure refined to 2A of a nicked DNA octanucleotide complex with DNase I. Nature 332:464–468;1988.
Suck D, Oefner C. Structure of DNase I at 2.0 A resolution suggests a mechanism for binding to and cutting DNA. Nature 321:620–625;1986.
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277;1982.
Tew MB, Johnson RW, Reveille JD, Tan FK. A molecular analysis of the low serum deoxyribonuclease activity in lupus patients. Arthritis Rheum 44:2446–2447;2001.
Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354;1979.
Walport MJ. Lupus, DNase and defective disposal of cellular debris. Nat Genet 25:135–136;2000.
Yasutomo K: Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus. Rheumatology (Oxf) 42:214–222;2003.
Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, Kuroda Y. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 28:313–314;2001.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yeh, TM., Chang, HC., Liang, CC. et al. Deoxyribonuclease-Inhibitory antibodies in systemic lupus erythematosus. J Biomed Sci 10, 544–551 (2003). https://doi.org/10.1007/BF02256116
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02256116